HOMOLOGY MEDICINES INC (FIXX)
Institutional ownership reported to the SEC as of Q2 2026, across 24 quarters.
1
Reporting holders
$1
Reported value
0.0%
Held as options
+0
Holder change
Options share is the part of reported value carried in derivative lines rather than shares. A high figure means institutions are expressing a view on this security without owning much of it.
Holders
| Filer | Value | Shares | Their book | Held | Change |
|---|---|---|---|---|---|
| KERR FINANCIAL PLANNING Corp | $1 | 600 | 0.00% | 2q | HELD |
Quarter by quarter
Coverage begins with the quarter ending 2018-12-31. Earlier filings exist only as occasional late amendments, too sparse to describe a market, so they are not shown.
| Quarter | Holders | Value | Shares | New | Added | Trimmed | Options |
|---|---|---|---|---|---|---|---|
| Q2 2026 | 1 | $1 | 600 | 0 | 0 | 0 | 0.0% |
| Q1 2026 | 1 | $0 | 600 | 1 | 0 | 0 | 0.0% |
| Q1 2024 | 1 | $1 | 1 | 0 | 0 | 0 | 0.0% |
| Q4 2023 | 54 | $11.3M | 18,544,238 | 6 | 7 | 10 | 0.2% |
| Q3 2023 | 56 | $20.5M | 17,489,716 | 5 | 5 | 15 | 0.4% |
| Q2 2023 | 57 | $15.4M | 17,412,335 | 6 | 6 | 16 | 0.2% |
| Q1 2023 | 53 | $19.1M | 18,522,300 | 3 | 9 | 10 | 0.2% |
| Q4 2022 | 65 | $24.3M | 19,238,404 | 15 | 8 | 15 | 0.4% |
| Q3 2022 | 77 | $38.8M | 23,996,495 | 9 | 14 | 27 | 0.3% |
| Q2 2022 | 80 | $51.1M | 25,353,899 | 17 | 19 | 28 | 2.2% |
| Q1 2022 | 102 | $93.6M | 29,607,024 | 10 | 27 | 37 | 3.8% |
| Q4 2021 | 117 | $125.4M | 34,034,713 | 15 | 41 | 26 | 1.2% |
| Q3 2021 | 118 | $254.4M | 32,034,394 | 17 | 34 | 29 | 0.9% |
| Q2 2021 | 116 | $241.2M | 33,001,345 | 26 | 50 | 16 | 0.6% |
| Q1 2021 | 110 | $275.5M | 28,989,881 | 18 | 27 | 30 | 0.9% |
| Q4 2020 | 106 | $349.0M | 30,466,831 | 17 | 33 | 33 | 1.3% |
| Q3 2020 | 104 | $369.8M | 34,218,227 | 23 | 25 | 36 | 1.1% |
| Q2 2020 | 103 | $575.9M | 37,789,204 | 25 | 52 | 14 | 0.3% |
| Q1 2020 | 90 | $583.5M | 37,465,331 | 17 | 25 | 28 | 0.2% |
| Q4 2019 | 86 | $764.2M | 36,871,651 | 19 | 26 | 20 | 0.1% |
| Q3 2019 | 81 | $569.2M | 31,427,057 | 15 | 35 | 14 | 0.0% |
| Q2 2019 | 86 | $588.4M | 30,093,689 | 29 | 40 | 9 | 0.0% |
| Q1 2019 | 66 | $643.1M | 23,189,961 | 9 | 25 | 14 | 0.0% |
| Q4 2018 | 65 | $512.1M | 22,903,458 | 3 | 1 | 1 | 0.0% |